Company intelligence / Profile preview

Pulxion Medical Technology

Ownership: Private
Development stage: Preclinical

Overview

Pulxion’s flagship product, PulStroke, is a non-invasive, rapid screening device for carotid artery stenosis—an early indicator of stroke. The system uses proprietary AI algorithms and imaging to provide quick, professional-grade assessments without the need for highly trained operators. Clinical validation has demonstrated its ability to identify high-risk individuals efficiently in community and clinical settings.

Therapeutic areas: Cardiovascular
Modalities: DeviceAI-based diagnostic technologyNon-invasive imaging technology
Industry: Medical Imaging

Partnerships

Medtronic (strategic partnership announced April 2025)National Taiwan University Hospital (clinical collaboration)

Beyond the preview

Go deeper on Pulxion Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulxion Medical Technology.

Explore the full profile